The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The epidemiology and risk factors of chronic polyneuropathy
Open accessAbstract
Polyneuropathy is a disabling condition of the peripheral nerves, characterized by symmetrical distal numbness and paresthesia, often accompanied with pain and weakness. Although the disease is often encountered in neurological clinics and is well known by physicians, incidence and prevalence rates are not well known. We searched EMBASE, Medline, Web-of-science, Cochrane, PubMed Publisher, and Google Scholar, for population-based studies investigating the prevalence of polyneuropathy and its risk factors. Out of 5119 papers, we identified 29 eligible studies, consisting of 11 door-to-door survey studies, 7 case-control studies and 11 cohort/database studies. Prevalence of polyneuropathy across these studies varies substantially. This can partly be explained by differences in assessment protocols and study populations. The overall prevalence of polyneuropathy in the general population seems around 1% and rises to up to 7% in the elderly. Polyneuropathy seemed more common in Western countries than in developing countries and there are indications that females are more often affected than males. Risk factor profiles differ across countries. In developing countries communicable diseases, like leprosy, are more common causes of neuropathy, whereas in Western countries especially diabetes, alcohol overconsumption, cytostatic drugs and cardiovascular disease are more commonly associated with polyneuropathy. In all studies a substantial proportion of polyneuropathy cases (20-30%) remains idiopathic. Most of these studies have been performed over 15 years ago. More recent evidence suggests that the prevalence of polyneuropathy in the general population has increased over the years. Future research is necessary to confirm this increase in prevalence and to identify new and potentially modifiable risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Causation and Causal Inference in Epidemiology
Rothman, K. J., & Greenland, S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.059204 · Cited by 1,259
Diabetic neuropathy: clinical manifestations and current treatments
Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L., & Feldman, E. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70065-0 · Cited by 1,211
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.121 · Cited by 1,101
Self-citationType 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923
Merkies, I. S. J., & Kieseier, B. C. (2016) · European Neurology · doi:10.1159/000445347 · Cited by 869
MacDonald, B. K. (2000) · Brain · doi:10.1093/brain/123.4.665 · Cited by 858
England, J. D., Gronseth, G. S., Franklin, G., Miller, R. G., Asbury, A. K., Carter, G. T., Cohen, J. A., Fisher, M. A., Howard, J. F., Kinsella, L. J., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000149522.32823.ea · Cited by 742
The spectrum of neuropathy in diabetes and impaired glucose tolerance
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R., & Polydefkis, M. (2003) · Neurology · doi:10.1212/wnl.60.1.108 · Cited by 708
Hughes, R. A., Donofrio, P., Bril, V., Dalakas, M. C., Deng, C., Hanna, K., Hartung, H.-P., Latov, N., Merkies, I. S., & van Doorn, P. A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70329-0 · Cited by 674
Self-citationNatural History of Peripheral Neuropathy in Patients with Non-Insulin-Dependent Diabetes Mellitus
Partanen, J., Niskanen, L., Lehtinen, J., Mervaala, E., Siitonen, O., & Uusitupa, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330203 · Cited by 656
Diagnosis, natural history, and management of Charcot–Marie–Tooth disease
Pareyson, D., & Marchesi, C. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70110-3 · Cited by 621
Ziegler, D., Rathmann, W., Dickhaus, T., Meisinger, C., Mielck, A., & for the KORA Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1796 · Cited by 397
Increased Prevalence of Impaired Glucose Tolerance in Patients With Painful Sensory Neuropathy
Singleton, J. R., Smith, A. G., & Bromberg, M. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1448 · Cited by 364
England, J. D., & Asbury, A. K. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16508-2 · Cited by 352
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Sima, A. A. F., & Feldman, E. L. (2009) · Diabetes · doi:10.2337/db08-1771 · Cited by 344
England, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000336345.70511.0f · Cited by 324
SENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Obesity and hyperlipidemia are risk factors for early diabetic neuropathy
Smith, A. G., & Singleton, J. R. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.003 · Cited by 272
England, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000336370.51010.a1 · Cited by 272
The Prevalence, Predictors, and Consequences of Peripheral Sensory Neuropathy in Older Patients
Mold, J. W., Vesely, S. K., Keyl, B. A., Schenk, J. B., & Roberts, M. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.5.309 · Cited by 258
Novella, S. P., Inzucchi, S. E., & Goldstein, J. M. (2001) · Muscle & Nerve · doi:10.1002/mus.1137 · Cited by 248
Painful sensory polyneuropathy associated with impaired glucose tolerance
Singleton, J. R., Smith, A. G., & Bromberg, M. B. (2001) · Muscle & Nerve · doi:10.1002/mus.1136 · Cited by 241
Symptoms of Sensory Neuropathy in Adults with NIDDM in the U.S. Population
Harris, M., Eastman, R., & Cowie, C. (1993) · Diabetes Care · doi:10.2337/diacare.16.11.1446 · Cited by 216
A community survey of neurological disorders in Saudi Arabia: the Thugbah Study
Al Rajeh, S., Bademosi, O., Ismail, H., Awada, A., Dawodu, A., Al-Freihi, H., Assuhaimi, S., Borollosi, M., & Al-Shammasi, S. (1993) · Neuroepidemiology · doi:10.1159/000110316 · Cited by 215
Costa, L. A., Canani, L. H., Lisbôa, H. R. K., Tres, G. S., & Gross, J. L. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01124.x · Cited by 197
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
England, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · PM&R · doi:10.1016/j.pmrj.2008.11.011 · Cited by 192
the Metascreen Writing Committee (2006) · Diabetes Care · doi:10.2337/dc06-0942 · Cited by 188
Neurological disorders in Nigerian Africans: a community-based study
Osuntokun, B., Adeuja, A., Schoenberg, B., Bademosi, O., Nottidge, V., Olumide, A., Lge, O., Yaria, F., & Bolis, C. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb07883.x · Cited by 184
Hyperlipidemia: a new therapeutic target for diabetic neuropathy
Vincent, A. M., Hinder, L. M., Pop‐Busui, R., & Feldman, E. L. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00237.x · Cited by 178
A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy
Hughes, R. A. C. (2004) · Brain · doi:10.1093/brain/awh192 · Cited by 178
Notermans, N. C., Wokke, J. H., Franssen, H., van der Graaf, Y., Vermeulen, M., van den Berg, L. H., Bar, P. R., & Jennekens, F. G. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.10.1066 · Cited by 174
Alcohol‐related peripheral neuropathy: Nutritional, toxic, or both?
Mellion, M. L., Gilchrist, J. M., & de la Monte, S. M. (2011) · Muscle & Nerve · doi:10.1002/mus.21946 · Cited by 154
Chronic Cryptogenic Sensory Polyneuropathy
Wolfe, G. I., Baker, N. S., Amato, A. A., Jackson, C. E., Nations, S., Saperstein, D., Choon, H., Katz, J., Bryan, W. W., & Barohn, R. J. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.540 · Cited by 148
Genetic epidemiology of Charcot-Marie-Tooth disease
Braathen, G. J. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12013 · Cited by 148
Chronic polyneuropathies in Vest‐Agder, Norway
Mygland, Å., & Monstad, P. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00187.x · Cited by 148
Koike, H., & Sobue, G. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000245371.89941.eb · Cited by 144
England, J. D., Gronseth, G., Franklin, G. M., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · PM&R · doi:10.1016/j.pmrj.2008.11.010 · Cited by 143
Research Protocol for Measuring the Prevalence of Neurologic Disorders in Developing Countries
Osuntokun, B. O., Schoenberg, B. S., Nottidge, V. A., Adeuja, A. O. G., Kale, O. O., Adeyefa, A., Bademosi, O., Olumide, A. A., Oyediran, A. B., Pearson, C. A., et al. (2007) · Neuroepidemiology · doi:10.1159/000110696 · Cited by 133
Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort
Eisen, S. A., Kang, H. K., Murphy, F. M., Blanchard, M. S., Reda, D. J., Henderson, W. G., Toomey, R., Jackson, L. W., Alpern, R., Parks, B. J., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-11-200506070-00005 · Cited by 127
Incidence of polyneuropathy in Utrecht, the Netherlands
Visser, N. A., Notermans, N. C., Linssen, R. S. N., van den Berg, L. H., & Vrancken, A. F. J. E. (2014) · Neurology · doi:10.1212/wnl.0000000000001160 · Cited by 127
Chronic symmetric symptomatic polyneuropathy in the elderly
(1995) · Neurology · doi:10.1212/wnl.45.10.1832 · Cited by 127
Lü, B., Hu, J., Wen, J., Zhang, Z., Zhou, L., Li, Y., & Hu, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061053 · Cited by 124
Idiopathic neuropathy patients are at high risk for metabolic syndrome
Smith, A. G., Rose, K., & Singleton, J. R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.005 · Cited by 123
Chronic idiopathic axonal polyneuropathy: a five year follow up.
Notermans, N. C., Wokke, J. H. J., van der Graaf, Y., Franssen, H., van Dijk, G. W., & Jennekens, F. G. I. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.12.1525 · Cited by 116
Prevalence of peripheral neuropathy in the Parsi community of Bombay
Bharucha, N. E., (Canada), N., Bharucha, A. E., Bharucha, E. P., & Bom), (. &. (1991) · Neurology · doi:10.1212/wnl.41.8.1315 · Cited by 113
The Prevalence of Diabetic Distal Sensory Neuropathy in an English Community
Walters, D., Catling, W., Mullee, M., & Hill, R. D. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01795.x · Cited by 108
Leiter, L. A. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.015 · Cited by 105
Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline
Rosenberg, N. R. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.2.205 · Cited by 101
Hoffman-Snyder, C., Smith, B. E., Ross, M. A., Hernandez, J., & Bosch, E. P. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.noc50336 · Cited by 100
Impaired Glycemia and Diabetic Polyneuropathy
Dyck, P. J. B., Clark, V. M., Overland, C. J., Davies, J. L., Pach, J. M., Dyck, P. J. B., Klein, C. J., Rizza, R. A., Melton, L. J., Carter, R. E., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1421 · Cited by 99
Prevalence and risk factors for neuropathy in a Canadian First Nation community
Bruce, S. G., & Young, T. K. (2008) · Diabetes Care · doi:10.2337/dc08-0278 · Cited by 90 · cited 2×
“In a study conducted in Canada, an adult population with a very high prevalence of diabetes (29 %) was investigated and an overall crude neuropathy prevalence of 7 % was reported [36].”
BackgroundPeripheral neuropathy in young‐old and old‐old patients
Verghese, J., Bieri, P. L., Gellido, C. L., Schaumburg, H. H., & Herskovitz, S. (2001) · Muscle & Nerve · doi:10.1002/mus.1171 · Cited by 89
Epidemiology of distal symmetrical neuropathies in the Italian elderly
Baldereschi, M., Inzitari, M., Carlo, A. D., Farchi, G., Scafato, E., & Inzitari, D. (2007) · Neurology · doi:10.1212/01.wnl.0000260606.36443.29 · Cited by 84
Chronic Idiopathic Axonal Polyneuropathy Is Associated With the Metabolic Syndrome
Visser, N. A., Vrancken, A. F. J. E., van der Schouw, Y. T., van den Berg, L. H., & Notermans, N. C. (2012) · Diabetes Care · doi:10.2337/dc12-0469 · Cited by 74
Prevalence of neurological disorders in Udo, a rural community in southern Nigeria.
Longe, A. C., & Bo, O. (1989) · PubMed · Cited by 70
Evaluation of Patients With Symptoms Suggestive of Chronic Polyneuropathy
Johannsen, L. G., Smith, T., Havsager, A., Madsen, C., Kjeldsen, M. J., Dalsgaard, N. J., Gaist, D., Schrøder, H. D., & Sindrup, S. H. (2001) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200112000-00001 · Cited by 66
Beghi, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00039-0 · Cited by 60
Idiopathic neuropathy: new paradigms, new promise
Singer, M. A., Vernino, S. A., & Wolfe, G. I. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00395.x · Cited by 59
Prevalence of diabetic neuropathy with somatic symptoms
Savettieri, G., Rocca, W. A., Salemi, G., Meneghini, F., Grigoletto, F., Morgante, F., Reggio, A., Costa, V., Coraci, M. A., & Perri, R. D. (1993) · Neurology · doi:10.1212/wnl.43.6.1115 · Cited by 56
Quality of life in patients with axonal polyneuropathy
Teunissen, L. L., Eurelings, M., Notermans, N. C., Hop, J. W., & van Gijn, J. (2000) · Journal of Neurology · doi:10.1007/s004150050562 · Cited by 54
The prevalence of neurological disorders in older people in Tanzania
Dewhurst, F., Dewhurst, M. J., Gray, W. K., Aris, E. A., Orega, G. P., Howlett, W. P., Warren, N., & Walker, R. W. (2012) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2012.01709.x · Cited by 51
CAUSES OF POLYNEUROPATHY IN THE ELDERLY
GEORGE, J., & Twomey, J. A. (1986) · Age and Ageing · doi:10.1093/ageing/15.4.247 · Cited by 48
Hospital‐referred polyneuropathies‐causes, prevalences, clinical‐ and neurophysiological findings
Rudolph, T. J., & Farbu, E. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01758.x · Cited by 34
Prevalence of Neurological Diseases in Madrid, Spain
Maria Cruz Gutierrez-del-Olmo, A., Schoenberg, B. S., & Portera‐Sánchez, A. (1988) · Neuroepidemiology · doi:10.1159/000110164 · Cited by 32
Prevalence of Neurological Disorders in a Japanese Town
Nakashima, K., Yokoyama, Y., Shimoyama, R., Saito, H., Kuno, N., Sano, K., Rin, Y., Adachi, Y., Urakami, K., Oshima, T., et al. (1996) · Neuroepidemiology · doi:10.1159/000109909 · Cited by 32
Vrancken, A. F. J. E. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.073239 · Cited by 30
Kruja, J., Beghi, E., Zerbi, D., Dobi, D., Kuqo, A., Zekja, I., Mijo, S., Kapisyzi, M., & Messina, P. (2012) · Neuroepidemiology · doi:10.1159/000336348 · Cited by 25
Drug therapy for chronic idiopathic axonal polyneuropathy
Warendorf, J. K., Vrancken, A. F. J. E., van Schaik, I. N., Hughes, R. A., & Notermans, N. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003456.pub3 · Cited by 24
Dyslipidaemia in chronic acquired distal axonal polyneuropathy
Rajabally, Y. A., & Shah, R. S. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5950-z · Cited by 18
Diabetes and Its Chronic Complications in the She Ethnic Minority Group of China
Lin, Y., Xu, Y., Chen, G., Lai, X., Huang, B., Chen, Z., Yao, L.-T., Zhu, S., Yao, J. Y., Wen, J., et al. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0244 · Cited by 18
Drug therapy for chronic idiopathic axonal polyneuropathy
Vrancken, A. F. J. E., van Schaik, I. N., Hughes, R. A., & Notermans, N. C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003456.pub2 · Cited by 9
Cited by
The Rotterdam Study: 2018 update on objectives, design and main results
Ikram, M. A., Brusselle, G. G. O., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., Stricker, B. H., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0321-4 · Cited by 434
Self-citationDiabetic peripheral neuropathy: pathogenetic mechanisms and treatment
Zhu, J., Hu, Z., Luo, Y., Liu, Y., Luo, W., Du, X., Luo, Z., Hu, J., & Peng, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265372 · Cited by 310
Jensen, T. S., Karlsson, P., Gylfadottir, S. S., Andersen, S. T., Bennett, D. L., Tankisi, H., Finnerup, N. B., Terkelsen, A. J., Khan, K., Themistocleous, A. C., et al. (2021) · Brain · doi:10.1093/brain/awab079 · Cited by 265
The Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Metadata
- Authors
- Hanewinckel, R., van Oijen, M., Ikram, M. A., & van Doorn, P. A.
- Venue
- European Journal of Epidemiology
- Published
- 2015-12-23
- Volume
- 31
- Issue
- 1
- Pages
- 5-20
- ISSN
- 0393-2990 (ISSN-L)
- 1573-7284
- OpenAlex
- W2277951273
- Cited by
- 293
- References
- 75
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.